Daily FNArena News - Australia

Following FY22 results, brokers set higher price targets for ResMed on average and expect market share gains

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Block’s buy now pay later segment continues to drag on portfolio performance, but brokers largely continue to back the integration opportunity for Afterpay and Cash App

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

An in-line result from Aurizon Holdings was somewhat overshadowed by guidance for FY23 that has largely disappointed the brokers

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Independent Investment Research updates developments among Australia’s listed investment companies and provides comparative data

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments